insights_auto
Nega ALMKT tushdi 4,22%?
Batafsil oʻrganishchevron_right
ALMKT:EPA
Mauna Kea Technologies SA
0,089 €
arrow_downward
-4,22%(-0,0039) 1K
18-noy, 17:35:09 (GMT+1) · EUR
search
Barcha belgilar
| Belgi | Narxi | Oʻzgartirishlar | Dinamika (%) |
|---|
insights_autoALMKT tikeri uchun statistika yaratilmoqda...
Ochish
0,09 €
Yuqori
0,09 €
Past
0,09 €
Bozor kapitali
17,68 mln
Oʻrtacha hajm
481,42 ming
Hajmi
152,44 ming
P/E koeffitsiyenti
0,75
52 haftalik eng yuqori
0,23 €
52 haftalik eng past
0,07 €
Aksiya boʻyicha daromad
0,12 €
Muomaladagi aksiyalar
195,26 mln
Xodimlar soni
56
Ochish
0,09 €
Yuqori
0,09 €
Past
0,09 €
Bozor kapitali
17,68 mln
Oʻrtacha hajm
481,42 ming
Hajmi
152,44 ming
P/E koeffitsiyenti
0,75
52 haftalik eng yuqori
0,23 €
52 haftalik eng past
0,07 €
Aksiya boʻyicha daromad
0,12 €
Muomaladagi aksiyalar
195,26 mln
Xodimlar soni
56
Yangiliklar
Internet manbalari va yangilik hamkorlarimizdan
Yahoo Finance
·
1 soat oldin
Nasdaq, Dow, S&P 500 Futures Climb Ahead Of Anthropic’s Record Debut: SLS, GLD, TTWO, UNH In Focus
Barron's
·
6 soat oldin
Generac Jolted After Nvidia Earnings. Why It’s a Top S&P 500 Stock Today.
The Motley Fool
·
1 soat oldin
The S&P 500 Just Ended a Run of 155 Trading Days Above Its 200-Day Average. Here's What Followed 34 Similar Runs Since 1950.
Hedgeye
·
15 soat oldin
Why Negative Gamma Has Taken the Brakes Off the S&P 500
Profil
Mauna Kea Technologies is a global medical device company focused on endomicroscopy, the field of microscopic imaging during endoscopy procedures. The company researches, develops and markets tools to visualize, detect, and rule out abnormalities including malignant and pre-malignant tumors or lesions in the gastrointestinal and pulmonary tracts.
The company makes Cellvizio, a probe-based Confocal Laser Endomicroscopy system, which provides physicians and researchers with real-time access to histological information during standard endoscopy procedures through high-resolution cellular imaging of internal tissues.
Cellvizio is used in medical applications such as gastrointestinal endoscopy, pulmonology and urology to help physicians diagnose lesions and make accurate treatment decisions in real-time.
Cellvizio went public in July 2011 and trades on the Euronext Paris exchange. Wikipedia
Mauna Kea Technologies SA haqida
CEOSacha Loiseau
Xodimlar soni56
Asos solingan2000
Bosh ofislar-
SektorHealth Care
Soha-
Veb-saytmaunakeatech.com